PTC124-GD-023-CF: An Open-Label Safety and Efficacy Study for Patients with Nonsense Mutation Cystic Fibrosis Previously Treated with Ataluren (PTC124®)

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/14 → 8/31/50

Funding

  • PTC Therapeutics, Inc. (PTC124-GD-023-CF)